SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-049419
Filing Date
2021-08-03
Accepted
2021-08-03 17:39:40
Documents
2
Period of Report
2021-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1609
2 EX-24 DOCUMENT attachment1.htm EX-24 2155
  Complete submission text file 0001209191-21-049419.txt   5216
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Takimoto Chris H (Reporting) CIK: 0001743780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39045 | Film No.: 211141273